SCHEMBL19804137

SCHEMBL19804137

C=C(C)C(=O)OCCOc1cc(-c2ccc(C)cc2)ccc1OCCO

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
KDM4E B2RXH2 1/20 0.38
GAA P10253 1/20 0.38
KMT2A Q03164 1/20 0.38
PDE4A P27815 3/20 0.37
PDE4B Q07343 3/20 0.37
PDE4C Q08493 3/20 0.37
PDE4D Q08499 3/20 0.37
HTT P42858 2/20 0.37
POLB P06746 1/20 0.37
APEX1 P27695 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
THRB P10828 1/20 0.37
SYK P43405 2/20 0.36
LMNA P02545 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MAPT P10636 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19624496 1.00 CA1 (0.40) CA1CA2KDM4EGAAKMT2A
SCHEMBL19804521 0.90 PDE4A (0.45) KDM4EGAAKMT2APDE4APDE4B
SCHEMBL15338837 0.89 THRB (0.45) CA1CA2KDM4EGAAKMT2A
SCHEMBL19803962 0.88 CA1 (0.39) CA1CA2PDE4APDE4BPDE4C
SCHEMBL19804141 0.88 CA1 (0.39) CA1CA2HTTPOLBAPEX1
SCHEMBL19804383 0.87 SLC6A9 (0.44) KDM4EGAAKMT2APDE4APDE4B
SCHEMBL19796247 0.87 PDE4A (0.40) KDM4EGAAKMT2APDE4APDE4B
SCHEMBL19804199 0.86 CA1 (0.39) CA1CA2PDE4APDE4BPDE4C
SCHEMBL19187406 0.86 TSHR (0.40) CA1CA2KDM4EKMT2APDE4A
SCHEMBL21400771 0.85 SYK (0.39) CA1CA2KDM4EPDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, C1S, AP3D1 CA1 489/4885CA2 2120/4885KDM4E 1906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.